The Launch of bone health assessment using a patented online service

Spire Roding will be the first hospital in the Spire group to use Sectra's online service which identifies at an early stage people at risk of getting osteoporotic fractures.


Spire Healthcare has a special focus on preventive care since its acquisition of Lifescan in 2011. Lifescan is one of the UK’s leading independent providers of CT health checks. Their aim is to identify the early signs of heart disease, colon cancer, and lung cancer; three of the four main causes of death in the UK. Now with Sectra OneScreen, they can include checking for osteoporosis.

“Osteoporosis can be an under-diagnosed disease and there is great need for simple, cost-effective methods of identifying patients in need of treatment,” says Dr John Giles, Clinical Director of Lifescan Ltd. “Being able to offer this additional service at Spire Roding Hospital is a great start and we would like to ultimately expand availability to more hospitals offering the Lifescan range of health checks.”

Osteoporosis is one of the most painful and costly diseases in the world. It primarily affects women, particularly after the menopause where every third woman is at risk of having a fragility fracture due to osteoporosis, which can cause great pain. Unfortunately several medicines for other conditions may have the side effect of bone loss and osteoporosis and cost- effective monitoring of these patients is another reason to use the Sectra service.

“We will increase our focus on osteoporosis health assessments with the availability of Sectra OneScreen on all digital modalities. This service fits very well with our ambition to deliver superior preventive care with Lifescan,” says Phillip Jones, Paramedical Services Manager at Spire Roding Hospital.

With Sectra’s service, patients at high risk of fracture can be identified and preventive care can be initiated. Additionally, Sectra’s service helps clinics identify women who should have their bone health (Bone Mineral Density, BMD) further investigated using a DXA scanner.

About Sectra OneScreen
Osteoporosis is a very under-diagnosed disease and a simple method for identifying patients requiring treatment is needed. The Sectra OneScreen online service is a cost-efficient solution for identifying patients at risk of osteoporosis. The service is well suited to the mammography workflow. After the four breast images included in the mammography examination, an image of the hand is acquired using the same radiology equipment. Since the woman is already standing by the modality, this adds no more than 30 seconds to the examination time. With the standard X-ray image of the hand, the women’s bone health (Bone Mineral Density, BMD) is analyzed using Sectra’s online service.

Clinics in Germany, Italy, Norway, Switzerland, France, and the UK have introduced Sectra OneScreen into their mammography service.

Benefits women, mammography clinics and society
The benefits of using Sectra’s online service to identify patients at risk of osteoporosis include:

  • Allowing women to assess and take control of their bone health, thereby avoiding fractures and unnecessary suffering.
  • Identification of women at high risk of fractures, meaning that treatment or further investigation using DXA scanning can be initiated.
  • The woman only needs to visit once for two examinations.
  • Seamless integration into the regular mammography workflow. Possibility of combining two examinations into one visit, adding only 30 seconds per woman.
  • No radiologist time needed. The procedure is based on FDA and CE-approved automatic image analysis done “in the cloud” while preserving patient integrity.
  • No need for new hardware – no major initial investment. Can be used with all major digital mammography devices.
  • Improvement of the bottom line for clinics and hospitals by doing more on the same visit. Also generates new and more patients for existing DXA systems.
  • Reduction in healthcare costs for insurance companies and society.
  • Primary osteoporosis affects primarily women in post-menopausal age. Secondary Osteoporosis affects also people with certain diseases such as Rheumatoid Arthritis but is also a known side effect from for example prostate as well as breast cancer treatment.

About osteoporosis

  • Some 200 million people are estimated to suffer from osteoporosis.
  • The disease is caused by an imbalance in the remodeling of the skeleton, which in turn can be caused, for example, by an unhealthy lifestyle, genetic factors or drugs used to treat other diseases.
  • Nine million osteoporosis-related fractures, primarily radio carpal, hip and vertebra fractures occur annually.
  • Affects one in three women, and one in five men, over the age of 50.
  • One of the diseases that causes the highest economic burden for healthcare.

Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...

Call 020 8709 7856 for an appointment

Bone Mineral Density Scanning Now Available at the Spire Roding

You can ask our friendly team for  a guide price or for more information about any of our diagnostic procedures. Alternatively, enquire online.

The benefits of private scans, tests and investigations at Spire Roding Hospital

You can expect:

  • High levels of comfort and safety
  • Convenient appointment times
  • Competitive pricing
  • Highly skilled and supportive staff
  • Easy access with free car parking

All tests are performed by experienced technicians using equipment of the highest quality. You will be cared for in a clean and comfortable hospital environment.

Click here for information on how to arrange a private test or scan at a Spire hospital.

© Spire Healthcare Group plc (2016)